サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631382

骨と関節の健康サプリメントの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Bone and Joint Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 176 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
骨と関節の健康サプリメントの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年01月06日
発行: Persistence Market Research
ページ情報: 英文 176 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の骨と関節の健康サプリメントの市場規模は、2025年に112億米ドルになるとみられ、2025年～2032年の予測期間に9.3%のCAGRで拡大し、2032年には208億米ドルに達すると予測されています。

骨と関節の健康サプリメントは、骨粗鬆症、関節炎、一般的な関節痛などの状態を管理するのに役立つ様々なソリューションを提供し、筋骨格系の健康を維持・改善する上で重要な役割を果たしています。これらのサプリメントには、グルコサミン、コンドロイチン、カルシウム、ビタミンD、コラーゲンなどの成分が含まれており、骨密度や関節の柔軟性をサポートするために一般的に使用されています。同市場は世界中の消費者を対象としており、製品は錠剤、カプセル、粉末、液体製剤など様々な形態で販売されています。市場成長の原動力は、骨と関節の健康に対する意識の高まり、世界人口の高齢化、予防ヘルスケアソリューションに対する需要の高まりです。

世界の骨と関節の健康サプリメント市場は、特に高齢化社会における変形性関節症や関節リウマチなどの関節関連疾患の有病率の上昇など、いくつかの主要な要因によって推進されています。骨の健康の重要性に対する消費者の意識の高まりは、天然で予防的なサプリメントに対する需要の高まりと相まって、市場の拡大をさらに後押ししています。コラーゲンベースや植物ベースの代替品の開発を含むサプリメント製剤の技術的進歩は、市場成長の新たな機会を提供します。さらに、スポーツ栄養とウェルネスへの関心の高まりも、特に若年層における関節健康製品の需要を促進しています。

骨と関節の健康サプリメント市場は、個別化栄養学の新たな動向と、製品流通におけるeコマースプラットフォームの採用増加により、大きな成長機会をもたらしています。研究の進歩により、生物学的に利用可能なコラーゲンや植物由来の代替品など、骨と関節のサプリメントの効能を高める新たな成分や配合が明らかになりつつあります。戦略的パートナーシップ、研究開発への投資、アスリート、高齢者、慢性関節痛患者など特定の層をターゲットとしたソリューションの導入は、新たな市場セグメントを獲得する重要な機会です。さらに、予防ヘルスケアへの傾向の高まりは、既存市場と新興市場の両方において、成長の好機となります。

当レポートでは、世界の骨と関節の健康サプリメント市場について調査し、形態別、エンドユーザー別、流通チャネル別、成分タイプ別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

第3章 骨と関節の健康サプリメント市場の産業構造

第4章 骨と関節の健康サプリメント市場の視点

  • マクロ経済要因
  • 機会分析
  • 世界経済見通し
  • 主要な規制シナリオ
  • 市場力学
  • 市場動向

第5章 世界の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）、地域別

第6章 世界の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）、形態別

第7章 世界の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）、エンドユーザー別

第8章 世界の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）、流通チャネル別

第9章 世界の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）、成分タイプ別

第10章 北米の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）

第11章 ラテンアメリカの骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）

第12章 欧州の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）

第13章 アジア太平洋の骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）

第14章 中東・アフリカの骨と関節の健康サプリメント市場分析（2019年～2024年）および予測（2025年～2032年）

第15章 予測要因：関連性と影響

第16章 競合情勢（メーカー/サプライヤー）

  • 競合ダッシュボード
  • 競合の進展（合併、買収、拡大）
  • ボリュームシェア分析
  • 競合の詳細
    • Koninklijke DSM N.V.
    • Glanbia PLC
    • Bayer AG
    • Kerry Group PLC
    • BASF SE
    • Alticor Inc.
    • NOW Health Group, Inc.
    • USANA Health Sciences, Inc.
    • Nutramax Laboratories, Inc.
    • Herbalife International
    • Nature's Bounty Co.
    • Abbott Laboratories
    • Bio-Tech Pharmacal Inc.
    • Seroyal International Inc.
    • NutriGold Inc.
    • その他

第17章 使用される仮定と頭字語

第18章 調査手法

目次
Product Code: PMRREP23539

Persistence Market Research has recently released a comprehensive report on the worldwide Bone and Joint Health Supplements Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bone and joint health supplements market from 2025 to 2032.

Key Insights:

  • Bone and Joint Health Supplements Market Size (2025E): USD 11.2 Billion
  • Projected Market Value (2032F): USD 20.8 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Bone and Joint Health Supplements Market - Report Scope:

Bone and joint health supplements play a crucial role in maintaining and improving musculoskeletal health, offering various solutions to help manage conditions such as osteoporosis, arthritis, and general joint pain. These supplements include ingredients like glucosamine, chondroitin, calcium, vitamin D, and collagen, which are commonly used to support bone density and joint flexibility. The market caters to consumers worldwide, with products available in various forms such as tablets, capsules, powders, and liquid formulations. Market growth is driven by increasing awareness of bone and joint health, the aging global population, and rising demand for preventive healthcare solutions.

Market Growth Drivers:

The global bone and joint health supplements market is propelled by several key factors, including the growing prevalence of joint-related disorders, such as osteoarthritis and rheumatoid arthritis, particularly among the aging population. Increased consumer awareness about the importance of bone health, coupled with the rising demand for natural and preventive supplements, further drives market expansion. Technological advancements in supplement formulations, including the development of collagen-based and plant-based alternatives, offer new opportunities for market growth. Moreover, the surge in interest in sports nutrition and wellness also fuels demand for joint health products, particularly among younger populations.

Market Restraints:

Despite promising growth prospects, the bone and joint health supplements market faces challenges related to regulatory hurdles, especially concerning the approval and claims made by supplement manufacturers. Concerns about the safety and efficacy of certain ingredients, such as glucosamine and chondroitin, can hinder consumer confidence in these products. Additionally, high market competition and the presence of counterfeit products pose challenges for manufacturers to maintain market share and ensure product quality. Limited healthcare coverage for non-prescription supplements in some regions may also affect consumer access and market penetration.

Market Opportunities:

The bone and joint health supplements market presents significant growth opportunities driven by emerging trends in personalized nutrition and the increasing adoption of e-commerce platforms for product distribution. Advances in research are unlocking new ingredients and formulations that enhance the efficacy of bone and joint supplements, such as bioavailable collagen and plant-based alternatives. Strategic partnerships, investment in R&D, and the introduction of targeted solutions for specific demographics, such as athletes, the elderly, and individuals with chronic joint pain, are key opportunities to capture new market segments. Furthermore, the growing trend toward preventive healthcare presents a lucrative opportunity for growth in both established and emerging markets.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bone and joint health supplements market globally?
  • Which ingredients and supplement forms are driving adoption in the market?
  • How are technological advancements in supplement formulations reshaping the competitive landscape?
  • Who are the key players contributing to the bone and joint health supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global bone and joint health supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global bone and joint health supplements market, including companies like Glanbia Nutritionals, Abbott Laboratories, and Nature's Bounty, focus on product innovation, marketing strategies, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop new and effective formulations, such as advanced collagen peptides and plant-based supplements. Collaborations with healthcare professionals, fitness influencers, and e-commerce platforms are helping market players reach a broader audience. Moreover, educating consumers on the benefits of joint health supplements through clinical research and direct-to-consumer marketing is driving brand loyalty and customer retention.

Key Companies Profiled:

  • Glanbia Nutritionals
  • Abbott Laboratories
  • Nature's Bounty
  • Herbalife Nutrition Ltd.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Amway Corporation
  • Omega Protein Corporation
  • Nestle Health Science
  • Solgar Inc.

Market Segmentation

By Form

  • Soft Gels/Pills
  • Powder
  • Liquid

By End User

  • Men
  • Women
  • Senior Citizen

By Distribution Channel

  • Pharmacies Drug Stores
  • Health & Beauty Stores
  • Specialty Stores
  • Online Sales

By Ingredient Type

  • Vitamins & Minerals
  • Amino Acids
  • Botanical Supplements

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Bone and Joint Health Supplements Market Industry Structure

  • 3.1. Market Structure
  • 3.2. Parent Market Overview
  • 3.3. Value Chain

4. Bone and Joint Health Supplements Market View Point

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis
  • 4.3. Global Economic Outlook
  • 4.4. Key Regulations Scenario
  • 4.5. Market Dynamics
  • 4.6. Market Trends
    • 4.6.1. Past Trends
    • 4.6.2. Forecast Trends

5. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Region

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size (US$ Bn) and Volume Analysis By Region, 2019 - 2024
  • 5.3. Market Size (US$ Bn) and Volume Forecast By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Latin America
    • 5.3.3. Europe
    • 5.3.4. Asia Pacific
    • 5.3.5. Middle East & Africa
  • 5.4. Market Attractiveness Analysis By Region

6. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Form

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Bn) and Volume Analysis By Form (2019 - 2024)
  • 6.3. Market Size (US$ Bn) and Volume Forecast By Form (2025 - 2032)
    • 6.3.1. Soft Gels/Pills
    • 6.3.2. Powder
    • 6.3.3. Liquid
  • 6.4. Market Attractiveness Analysis By Application

7. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By End User

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Bn) and Volume Analysis By End User (2019 - 2024)
  • 7.3. Market Size (US$ Bn) and Volume Forecast By End User (2025 - 2032)
    • 7.3.1. Men
    • 7.3.2. Women
    • 7.3.3. Senior Citizen
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis By End User

8. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Distribution Channel

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Bn) and Volume Analysis By Distribution Channel (2019 - 2024)
  • 8.3. Market Size (US$ Bn) and Volume Forecast By Distribution Channel (2025 - 2032)
    • 8.3.1. Pharmacies Drug Stores
    • 8.3.2. Health & Beauty Stores
    • 8.3.3. Specialty Stores
    • 8.3.4. Online Sales
    • 8.3.5. Other Sales Channel
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Ingredient Type

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Bn) and Volume Analysis By Ingredient Type (2019 - 2024)
  • 9.3. Market Size (US$ Bn) and Volume Forecast By Ingredient Type (2025 - 2032)
    • 9.3.1. Vitamins & Minerals
    • 9.3.2. Amino Acids
    • 9.3.3. Botanical Supplements
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Nature

10. North America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 10.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Form
    • 10.3.3. By End User
    • 10.3.4. By Distribution Channel
    • 10.3.5. By Ingredient Type
  • 10.4. Drivers and Restraints: Impact Analysis
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Form
    • 10.5.3. By End User
    • 10.5.4. By Distribution Channel
    • 10.5.5. By Ingredient Type

11. Latin America Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 11.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Argentina
      • 11.3.1.4. Rest of Latin America
    • 11.3.2. By Form
    • 11.3.3. By End User
    • 11.3.4. By Distribution Channel
    • 11.3.5. By Ingredient Type
  • 11.4. Drivers and Restraints: Impact Analysis
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Form
    • 11.5.3. By End User
    • 11.5.4. By Distribution Channel
    • 11.5.5. By Ingredient Type

12. Europe Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 12.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. Rest of Europe
    • 12.3.2. By Form
    • 12.3.3. By End User
    • 12.3.4. By Distribution Channel
    • 12.3.5. By Ingredient Type
  • 12.4. Drivers and Restraints: Impact Analysis
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Form
    • 12.5.3. By End User
    • 12.5.4. By Distribution Channel
    • 12.5.5. By Ingredient Type

13. Asia Pacific Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume Analysis By Market Segments (2019 - 2024)
  • 13.3. Market Size (US$ Bn) and Volume Forecast By Market Segments (2025 - 2032)
    • 13.3.1. By Country
      • 13.3.1.1. China
      • 13.3.1.2. India
      • 13.3.1.3. Japan
      • 13.3.1.4. ASEAN
      • 13.3.1.5. Australia & New Zealand
      • 13.3.1.6. Rest of APAC
    • 13.3.2. By Form
    • 13.3.3. By End User
    • 13.3.4. By Distribution Channel
    • 13.3.5. By Ingredient Type
  • 13.4. Drivers and Restraints: Impact Analysis
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Form
    • 13.5.3. By End User
    • 13.5.4. By Distribution Channel
    • 13.5.5. By Ingredient Type

14. Middle East & Africa Bone and Joint Health Supplements Market Analysis 2019 - 2024 and Forecast 2025 - 2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume Analysis By Price Range (2019 - 2024)
  • 14.3. Market Size (US$ Bn) and Volume Forecast By Price Range (2025 - 2032)
    • 14.3.1. By Country
      • 14.3.1.1. GCC Countries
      • 14.3.1.2. Northern Africa
      • 14.3.1.3. South Africa
      • 14.3.1.4. Rest of MEA
    • 14.3.2. By Form
    • 14.3.3. By End User
    • 14.3.4. By Distribution Channel
    • 14.3.5. By Ingredient Type
  • 14.4. Drivers and Restraints: Impact Analysis
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Form
    • 14.5.3. By End User
    • 14.5.4. By Distribution Channel
    • 14.5.5. By Ingredient Type

15. Forecast Factors: Relevance and Impact

16. Competition Landscape (Manufacturers/Suppliers)

  • 16.1. Competition Dashboard
  • 16.2. Competition Developments (Mergers, Acquisitions and Expansions)
  • 16.3. Volume Share Analysis
  • 16.4. Competition Deepdive
    • 16.4.1. Koninklijke DSM N.V.
      • 16.4.1.1. Overview
      • 16.4.1.2. Product Portfolio
      • 16.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.1.4. Sales Footprint
      • 16.4.1.5. Strategy Overview
    • 16.4.2. Glanbia PLC
      • 16.4.2.1. Overview
      • 16.4.2.2. Product Portfolio
      • 16.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.2.4. Sales Footprint
      • 16.4.2.5. Strategy Overview
    • 16.4.3. Bayer AG
      • 16.4.3.1. Overview
      • 16.4.3.2. Product Portfolio
      • 16.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.3.4. Production Footprint
      • 16.4.3.5. Sales Footprint
      • 16.4.3.6. Strategy Overview
    • 16.4.4. Kerry Group PLC
      • 16.4.4.1. Overview
      • 16.4.4.2. Product Portfolio
      • 16.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.4.4. Production Footprint
      • 16.4.4.5. Sales Footprint
      • 16.4.4.6. Strategy Overview
    • 16.4.5. BASF SE
      • 16.4.5.1. Overview
      • 16.4.5.2. Product Portfolio
      • 16.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.5.4. Sales Footprint
      • 16.4.5.5. Strategy Overview
    • 16.4.6. Alticor Inc.
      • 16.4.6.1. Overview
      • 16.4.6.2. Product Portfolio
      • 16.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.6.4. Sales Footprint
      • 16.4.6.5. Strategy Overview
    • 16.4.7. NOW Health Group, Inc.
      • 16.4.7.1. Overview
      • 16.4.7.2. Product Portfolio
      • 16.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.7.4. Sales Footprint
      • 16.4.7.5. Strategy Overview
    • 16.4.8. USANA Health Sciences, Inc.
      • 16.4.8.1. Overview
      • 16.4.8.2. Product Portfolio
      • 16.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.8.4. Sales Footprint
      • 16.4.8.5. Strategy Overview
    • 16.4.9. Nutramax Laboratories, Inc.
      • 16.4.9.1. Overview
      • 16.4.9.2. Product Portfolio
      • 16.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.9.4. Sales Footprint
      • 16.4.9.5. Strategy Overview
    • 16.4.10. Herbalife International
      • 16.4.10.1. Overview
      • 16.4.10.2. Product Portfolio
      • 16.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.10.4. Sales Footprint
      • 16.4.10.5. Strategy Overview
    • 16.4.11. Nature's Bounty Co.
      • 16.4.11.1. Overview
      • 16.4.11.2. Product Portfolio
      • 16.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.11.4. Sales Footprint
      • 16.4.11.5. Strategy Overview
    • 16.4.12. Abbott Laboratories
      • 16.4.12.1. Overview
      • 16.4.12.2. Product Portfolio
      • 16.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.12.4. Sales Footprint
      • 16.4.12.5. Strategy Overview
    • 16.4.13. Bio-Tech Pharmacal Inc.
      • 16.4.13.1. Overview
      • 16.4.13.2. Product Portfolio
      • 16.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.13.4. Sales Footprint
      • 16.4.13.5. Strategy Overview
    • 16.4.14. Seroyal International Inc.
      • 16.4.14.1. Overview
      • 16.4.14.2. Product Portfolio
      • 16.4.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.14.4. Sales Footprint
      • 16.4.14.5. Strategy Overview
    • 16.4.15. NutriGold Inc.
      • 16.4.15.1. Overview
      • 16.4.15.2. Product Portfolio
      • 16.4.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.15.4. Sales Footprint
      • 16.4.15.5. Strategy Overview
    • 16.4.16. Others
      • 16.4.16.1. Overview
      • 16.4.16.2. Product Portfolio
      • 16.4.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 16.4.16.4. Sales Footprint
      • 16.4.16.5. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology